$19.4 Thousand is the total value of TLS Advisors LLC's 14 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EQT | EQT CORP | $4,812 | -5.7% | 150,800 | 0.0% | 24.75% | -1.6% | |
| OVID | Sell | OVID THERAPEUTICS INC | $3,516 | +26.8% | 1,380,346 | -7.4% | 18.08% | +32.4% |
| XOMA | Sell | XOMA CORP | $2,543 | +11.4% | 120,465 | -2.9% | 13.08% | +16.3% |
| FB | Sell | META PLATFORMS INC-CLASS A | $2,244 | +27.8% | 10,589 | -27.4% | 11.54% | +33.3% |
| RRC | RANGE RESOURCES CORP | $1,584 | +956.0% | 59,823 | 0.0% | 8.15% | +1002.3% | |
| Sell | OMNIAB INC | $1,312 | -5.7% | 356,592 | -7.8% | 6.75% | -1.6% | |
| XENE | XENON PHARMACEUTICALS INC | $1,208 | -9.2% | 33,756 | 0.0% | 6.21% | -5.3% | |
| BLU | BELLUS HEALTH INC | $905 | -12.5% | 125,731 | 0.0% | 4.65% | -8.7% | |
| YNDX | YANDEX NV-A | $337 | 0.0% | 17,811 | 0.0% | 1.73% | +4.3% | |
| EWS | ISHARES MSCI SINGAPORE ETF | $270 | +5.9% | 13,600 | 0.0% | 1.39% | +10.5% | |
| HOV | Sell | HOVNANIAN ENTERPRISES-A | $263 | -3.3% | 3,872 | -40.2% | 1.35% | +0.9% |
| MEIP | Sell | MEI PHARMA INC COM STK | $244 | -50.2% | 1,064,995 | -47.0% | 1.26% | -48.0% |
| REGN | REGENERON PHARMACEUTICALS | $205 | +13.9% | 250 | 0.0% | 1.05% | +18.8% | |
| New | NEAR INTELLIGENCE INC | $1 | – | 10,000 | +100.0% | 0.01% | – | |
| INKAW | Exit | KLUDEIN I ACQUISITION-CW27 | $0 | – | -10,000 | -100.0% | -0.01% | – |
| NNDM | Exit | NANO DIMENSION LTD ADR | $0 | – | -22,000 | -100.0% | -0.25% | – |
| Exit | APTOSE BIOSCIENCES INC SHS | $0 | – | -89,403 | -100.0% | -0.26% | – | |
| NKTX | Exit | NKARTA INC REG SHS COM | $0 | – | -26,842 | -100.0% | -0.79% | – |
| AFMD | Exit | AFFIMED NV | $0 | – | -161,971 | -100.0% | -0.99% | – |
| FSTX | Exit | F-STAR THERAPEUTICS INC COM | $0 | – | -54,298 | -100.0% | -1.69% | – |
| TSLA | Exit | TESLA INC COM | $0 | – | -6,000 | -100.0% | -3.64% | – |
| SI | Exit | SILVERGATE CAPITAL CORP REGISTERE CL A | $0 | – | -79,795 | -100.0% | -6.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQT CORPORATION | 4 | Q3 2023 | 26.4% |
| OVID THERAPEUTICS INC | 4 | Q3 2023 | 20.5% |
| META PLATFORMS INC CLASS A COMMON STOCK COMMON STOCK | 4 | Q3 2023 | 13.0% |
| XOMA CORP COM | 4 | Q3 2023 | 13.1% |
| OMNIAB INC REG SHS COM | 4 | Q3 2023 | 6.9% |
| XENON PHARMACEUTICALS INC SHS | 4 | Q3 2023 | 6.6% |
| RANGE RESOURCES CORP | 4 | Q3 2023 | 8.1% |
| HOVNANIAN ENTERPRISES INC COM | 4 | Q3 2023 | 1.6% |
| ISHARES MSCI SINGAPORE ETF | 4 | Q3 2023 | 1.4% |
| YANDEX NV-A | 4 | Q3 2023 | 1.7% |
View TLS Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ovid Therapeutics Inc. | May 27, 2020 | 2,489,415 | 4.6% |
View TLS Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2020-05-27 |
| SC 13D/A | 2019-11-27 |
| SC 13D/A | 2019-10-07 |
| SC 13D | 2019-03-01 |
View TLS Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.